Skip to main content
Clinical Trials/NCT05380128
NCT05380128
Completed
Not Applicable

Association Study Between Vitamin D Receptor Gene Polymorphisms and Risk and Features of Myasthenia Gravis in Han Chinese Population

Beijing Tongren Hospital1 site in 1 country297 target enrollmentJune 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myasthenia Gravis, Ocular
Sponsor
Beijing Tongren Hospital
Enrollment
297
Locations
1
Primary Endpoint
Association between VDR gene polymorphism and MG susceptibility
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The Vitamin D receptor gene (VDR) polymorphisms are the candidate genetic variants for susceptibility to autoimmune diseases. In the present study, the investigators aimed to assess the association between VDR polymorphisms and myasthenia gravis (MG) susceptibility and disease features in Chinese Han population.The patients with MG and healthy controls were genotyped for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms using the improved multiple ligase detection reaction. Information on age at onset, acetylcholine receptor antibody (AChR-Ab) and muscle-specific kinase antibody (MuSK-Ab) status, thymus status, involved muscles at onset and Osserman type at the maximum worsening during 2 years follow-up were obtained and used as the grouping basis of sub-classifications. Intergroup comparisons of allele and genotype frequencies, haplotype distributions were performed between MG group and the control group, and between each pair of MG subgroups.

Registry
clinicaltrials.gov
Start Date
June 1, 2017
End Date
May 9, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Beijing Tongren Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of myasthenia gravis.
  • Han Chinese population.
  • Must be able to complete a 2-year follow-up visit.

Exclusion Criteria

  • Clinical data collection can not be completed.
  • Poor compliance.

Outcomes

Primary Outcomes

Association between VDR gene polymorphism and MG susceptibility

Time Frame: up to 2 years

Codominant, dominant and recessive genetic models and haplotype analysis were applied to compare the difference between MG and control groups.

Secondary Outcomes

  • Association of VDR gene polymorphism with MG subgroups(up to 2 years)

Study Sites (1)

Loading locations...

Similar Trials